$VMNT
Vemanti Group, Inc.

2022 Q3 Form 10-Q Financial Statement

#000147793222005959 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $35.10K $36.18K $37.60K
YoY Change -5.42% -3.99%
Cost Of Revenue $5.229K $6.652K $5.520K
YoY Change -9.91% 31.75%
Gross Profit $29.87K $29.53K $32.08K
YoY Change -4.59% -9.52%
Gross Profit Margin 85.1% 81.61% 85.32%
Selling, General & Admin $239.9K $293.8K $329.0K
YoY Change -60.5% -37.7%
% of Gross Profit 803.05% 995.02% 1025.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.230K $190.00 $184.00
YoY Change 4231.58% -48.65% -0.54%
% of Gross Profit 27.55% 0.64% 0.57%
Operating Expenses $239.9K $293.8K $328.9K
YoY Change -60.5% -37.7%
Operating Profit -$210.0K -$264.3K -$296.9K
YoY Change -63.54% -39.79%
Interest Expense $19.00 $13.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $185.00 $186.00 $436.00
YoY Change -117.32% -89.37% -126.41%
Pretax Income -$217.2K -$264.3K -$296.4K
YoY Change -62.36% -40.41% 323.68%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$217.2K -$264.3K -$296.4K
YoY Change -62.41% -40.52% 323.68%
Net Earnings / Revenue -618.77% -730.48% -788.39%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 71.91M shares 71.70M shares 70.95M shares
Diluted Shares Outstanding 69.18M shares 71.68M shares 70.95M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $318.5K $435.8K $540.9K
YoY Change -26.6% -5.08%
Cash & Equivalents $318.5K $435.8K $534.8K
Short-Term Investments $0.00 $0.00 $6.110K
Other Short-Term Assets $233.9K
YoY Change 3730.19%
Inventory
Prepaid Expenses $233.9K
Receivables $12.88K $7.606K $1.410K
Other Receivables $0.00 $0.00 $25.14K
Total Short-Term Assets $565.3K $443.4K $567.4K
YoY Change 22.84% -9.18%
LONG-TERM ASSETS
Property, Plant & Equipment $76.00 $261.00 $450.00
YoY Change -90.7% -73.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $296.4K
YoY Change -100.0% -100.0%
Total Long-Term Assets $313.6K $321.8K $296.9K
YoY Change 5.5% 8.2%
TOTAL ASSETS
Total Short-Term Assets $565.3K $443.4K $567.4K
Total Long-Term Assets $313.6K $321.8K $296.9K
Total Assets $878.9K $765.3K $864.3K
YoY Change 16.04% -2.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.973K $20.23K $10.18K
YoY Change -37.43% 98.95%
Accrued Expenses $442.4K $342.8K $279.8K
YoY Change 5.26% 119.24%
Deferred Revenue
YoY Change
Short-Term Debt $125.0K $125.0K $125.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $576.4K $488.1K $415.0K
YoY Change 32.61% 193.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $576.4K $488.1K $415.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $576.4K $488.1K $415.0K
YoY Change 2.99% 193.05%
SHAREHOLDERS EQUITY
Retained Earnings -$4.062M -$3.845M -$3.581M
YoY Change 47.65% 76.91%
Common Stock $6.917K $7.170K $7.151K
YoY Change -1.06% 2.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $302.5K $277.2K $449.3K
YoY Change
Total Liabilities & Shareholders Equity $878.9K $765.3K $864.3K
YoY Change 16.04% -2.6%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$217.2K -$264.3K -$296.4K
YoY Change -62.41% -40.52% 323.68%
Depreciation, Depletion And Amortization $8.230K $190.00 $184.00
YoY Change 4231.58% -48.65% -0.54%
Cash From Operating Activities -$117.4K -$104.8K -$98.65K
YoY Change -21.34% -46.65% 56.9%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $5.890K
YoY Change
Cash From Investing Activities $0.00 $5.890K $0.00
YoY Change -158.9% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $337.5K
YoY Change 27.36%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 $337.5K
YoY Change -100.0% -100.0% 27.36%
NET CHANGE
Cash From Operating Activities -117.4K -104.8K -$98.65K
Cash From Investing Activities 0.000 5.890K $0.00
Cash From Financing Activities 0.000 0.000 $337.5K
Net Change In Cash -117.4K -98.94K $238.9K
YoY Change 385.16% -147.45% 24.32%
FREE CASH FLOW
Cash From Operating Activities -$117.4K -$104.8K -$98.65K
Capital Expenditures $0.00
Free Cash Flow -$98.65K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
0 usd
CY2021Q4 us-gaap Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
25142 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
331601 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
261 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
632 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15727 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9090 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
800 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001605057
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
40000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
40000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71704004 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70404086 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56266
dei Entity Registrant Name
EntityRegistrantName
VEMANTI GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5317552
dei Entity Address Address Line1
EntityAddressAddressLine1
7545 Irvine Center Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
559-7200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71909858 shares
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
293824 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
471591 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-264295 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-438956 usd
CY2022Q2 us-gaap Other Income
OtherIncome
420 usd
CY2021Q2 us-gaap Other Income
OtherIncome
0 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
186 usd
CY2021Q2 us-gaap Other Expenses
OtherExpenses
1750 usd
CY2022Q2 vemanti Digital Assets
DigitalAssets
0 usd
CY2021Q4 vemanti Digital Assets
DigitalAssets
6107 usd
CY2022Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
321547 usd
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
0 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
0 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
296405 usd
CY2022Q2 us-gaap Assets
Assets
765254 usd
CY2021Q4 us-gaap Assets
Assets
628638 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20229 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4502 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71704004 shares
CY2022Q2 us-gaap Revenues
Revenues
36181 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
6652 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
29529 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
293824 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
13 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
13 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2022Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2021Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2825 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2825 usd
CY2022Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-221 usd
CY2021Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-221 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0 usd
CY2021Q2 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0 usd
us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0 usd
us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-1651 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4575 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
436 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6226 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-264295 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-443531 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-560730 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-513498 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-264295 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-444331 usd
us-gaap Net Income Loss
NetIncomeLoss
-560730 usd
us-gaap Net Income Loss
NetIncomeLoss
-514298 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
71683540 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
69541308 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
71319834 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
69347898 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71683540 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69541308 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71319834 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69347898 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
71843 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
337500 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
336390 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-296435 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
449298 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
92190 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-264295 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
277193 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
566955 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
265000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-69967 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
761988 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
150000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
151500 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-444331 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
619157 usd
us-gaap Profit Loss
ProfitLoss
-560730 usd
us-gaap Profit Loss
ProfitLoss
-514298 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1651 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2825 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-221 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
371 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
371 usd
us-gaap Share Based Compensation
ShareBasedCompensation
344119 usd
us-gaap Share Based Compensation
ShareBasedCompensation
151500 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3191 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2757 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
644 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
156375 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-613 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-203483 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-196500 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
5886 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
-10000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5886 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
337500 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
415000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
337500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
415000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
139903 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
208500 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295937 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243494 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
435840 usd
us-gaap Interest Paid Net
InterestPaidNet
13 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
vemanti Exchange Of Due From Fvndit For Intangible Assets
ExchangeOfDueFromFvnditForIntangibleAssets
25142 usd
vemanti Exchange Of Due From Fvndit For Intangible Assets
ExchangeOfDueFromFvnditForIntangibleAssets
0 usd
vemanti Exchange Of Intangible Assets For Assets
ExchangeOfIntangibleAssetsForAssets
321547 usd
vemanti Exchange Of Intangible Assets For Assets
ExchangeOfIntangibleAssetsForAssets
0 usd
vemanti Exchange Of Investment In Fvndit For Intangible Assets
ExchangeOfInvestmentInFvnditForIntangibleAssets
296405 usd
vemanti Exchange Of Investment In Fvndit For Intangible Assets
ExchangeOfInvestmentInFvnditForIntangibleAssets
0 usd
vemanti Reclassification Policytextblock
ReclassificationPolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain amounts reported in the prior year condensed consolidated financial statements have been reclassified to conform to the current year’s presentation.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, among others, allowances for doubtful accounts, valuation allowance for deferred income taxes and recoverability of other assets. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.</p>
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71704004 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70404086 shares
vemanti Stock Issued During Period Shares For Cash
StockIssuedDuringPeriodSharesForCash
631530 shares
vemanti Stock Issued During Period Value For Cash
StockIssuedDuringPeriodValueForCash
337500 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
668388 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
428580 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
25000 usd
CY2022Q2 us-gaap Investments
Investments
0 usd
CY2021Q4 us-gaap Investments
Investments
296405 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
0 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
0 usd
CY2022Q2 vemanti Proprietary Information
ProprietaryInformation
321547 usd
CY2021Q4 vemanti Proprietary Information
ProprietaryInformation
0 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
321547 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2022Q3 vemanti Description Of Subsequent Event
DescriptionOfSubsequentEvent
On August 5, 2022 the Company and CEO agreed to extend the $125,000 loan’s maturity date to August 5, 2023.

Files In Submission

Name View Source Status
0001477932-22-005959-index-headers.html Edgar Link pending
0001477932-22-005959-index.html Edgar Link pending
0001477932-22-005959.txt Edgar Link pending
0001477932-22-005959-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vemanti-20220630.xsd Edgar Link pending
vnmt_10q.htm Edgar Link pending
vnmt_ex311.htm Edgar Link pending
vnmt_ex312.htm Edgar Link pending
vnmt_ex321.htm Edgar Link pending
vnmt_ex322.htm Edgar Link pending
vemanti-20220630_def.xml Edgar Link unprocessable
vemanti-20220630_pre.xml Edgar Link unprocessable
vemanti-20220630_lab.xml Edgar Link unprocessable
vemanti-20220630_cal.xml Edgar Link unprocessable
vnmt_10q_htm.xml Edgar Link completed